LAB International (CC:LAB) Announces Name Change to Akela Pharma Inc.
7/12/2007 12:45:01 PM
More...
|
LAB International (CC:LAB) Announces Positive Results from its Growth Hormone Releasing Hormone (GHRH) Phase II Trial
7/12/2007 9:33:27 AM
More...
|
LAB International (CC:LAB) Licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica N.V. for Europe
6/21/2007 1:37:49 PM
More...
|
LAB International (CC:LAB) to Hold its Annual General Meeting of Shareholders June 22, 2007 in Montreal
6/19/2007 12:50:57 PM
More...
|
LAB International (CC:LAB) Reports Results for First Quarter of Fiscal 2007
5/15/2007 12:59:18 PM
More...
|
LAB International (CC:LAB) to Hold First Quarter 2007 Conference Call and Webcast
5/10/2007 1:46:48 PM
More...
|
LAB International (CC:LAB) Reports Results for Fourth Quarter and Fiscal 2006
3/26/2007 12:35:03 PM
More...
|
LAB International (CC:LAB) to Hold Fourth Quarter and Fiscal 2006 Conference Call and Webcast
3/21/2007 11:06:22 AM
More...
|
LAB International (CC:LAB) Announces Positive Results from the Open-Label Phase IIb Fentanyl TAIFUN(R) Trial - New Patent Application Submitted
3/5/2007 11:19:14 AM
More...
|
LAB International (CC:LAB) Completes Patient Enrollment In Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
2/8/2007 9:57:11 AM
More...
|
|